Subscribe

Ashley Gallagher

Articles by Ashley Gallagher

1-Year Data on Omidubicel Shows Sustained Benefits, Reduced Infection Rates

ByAshley Gallagher

May 2nd 2022

There was a continued trend toward improvement of overall survival with omidubicel at 73% compared with UCBT at 60%.

Cell Therapy for AML Granted Fast Track Designation

ByAshley Gallagher

September 16th 2021

A phase 1/2a clinical trial assessing VOR33 is currently enrolling.

Latest Updated Articles

Trending on CGTlive®

BLA for Rocket’s LAD-I Gene Therapy Under Review by FDA Again

Regeneron’s Gene Therapy DB-OTO Improves Speech Perception in Children With Otoferlin-Related Hearing Loss

Myrtelle’s Canavan Disease Gene Therapy Effects Significant Decrease in CSF NAA and Increases in Brain Myelin Volume

© 2025 MJH Life Sciences^®

All rights reserved.